Generics Subject To Solvay Sham Litigation Claims

Law360, New York (September 17, 2010, 11:28 AM EDT) -- A federal judge has kept alive claims alleging generics makers Par Pharmaceutical Cos. Inc. and Paddock Laboratories Inc. engaged in sham litigation by agreeing not to release competing versions of Solvay Pharmaceuticals Inc.’s testosterone supplement AndroGel.

Judge Thomas W. Thrash Jr. of the U.S. District Court for the Northern District of Georgia issued the order Thursday responding to the defendants' requests for clarification on whether he had dismissed those claims in a February ruling.

In that ruling, Judge Thrash knocked out all claims brought by the...
To view the full article, register now.